The demand for biopharmaceutical products is on the rise. It is expected that within 10 years, up to 50% of all drugs in development will be biopharmaceutical.
Precision medicine in Delaware is part of a larger picture of revolutionizing treatment for every body, according to its genetic makeup.
Work is underway at a $150 million manufacturing center, marking a new chapter of the next National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Center.
Title: Institute Director & Gore Professor Workplace: NIIMBL & University of Delaware Alma Maters: Princeton University, California Institute of Technology Boards: Delaware Bioscience Association, United States Manufacturing Innovation Council Q&A: […]
Gov. John Carney signed the $1.4 billion in capital improvement projects and $72 million in grants in aid for various service organizations.
Premier Digital Partners
© 2024 Delaware Business Times
